Top Markets
Coin of the day
Gujarat Themis Biosyn Ltd. Gujarat Themis Biosyn Ltd.

Gujarat Themis Biosyn Ltd.

GUJTHEM
Rank in Stocks #13260
Gujarat Themis Biosyn Ltd. is an Indian company primarily involved in the... Gujarat Themis Biosyn Ltd. is an Indian company primarily involved in the creation of pharmaceuticals and medicinal chemicals. The firm also supplies bulk drugs via a job work model within India. Its product offerings include important compounds such as Rifamycin-S, an intermediate used in treatments for tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease. Another key product, Rifamycin-O, addresses ailments like traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy. Furthermore, they produce Lovastatin. Established in 1981, the company's operations are based out of Mumbai, India.
Share Price
$4.66
Market Cap
$507.71M
Change (1 day)
2.94%
Change (1 year)
8.43%
Country
IN
Trade Gujarat Themis Biosyn Ltd. (GUJTHEM)

Category

Operating Margin for Gujarat Themis Biosyn Ltd. (GUJTHEM)
Operating Margin as of 2026 TTM: 0.00%
According to Gujarat Themis Biosyn Ltd. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Gujarat Themis Biosyn Ltd. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
0.00% -
DE
0.00% -
DE
0.00% -
JP
22.93% -
IN
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.